{"count": 6, "results": [{"_id": "38369200", "pmid": 38369200, "title": "The role of metformin in overactive bladder: more studies are warranted.", "journal": "Urology", "authors": ["Jiang S", "Wang R", "Liao J"], "date": "2024-02-16T00:00:00Z", "doi": "10.1016/j.urology.2023.11.038", "meta_date_publication": "2024 Feb 16", "meta_volume": "", "meta_issue": "", "meta_pages": "", "score": 50281.457, "text_hl": "The role of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ in @<m>DISEASE_Urinary_Bladder_Overactive</m> @DISEASE_MESH:D053201 @@@overactive bladder@@@: more studies are warranted.", "citations": {"NLM": "Jiang S, Wang R, Liao J. The role of metformin in overactive bladder: more studies are warranted. Urology. 2024 Feb 16;():. PMID: 38369200", "BibTeX": "@article{38369200, title={The role of metformin in overactive bladder: more studies are warranted.}, author={Jiang S and Wang R and Liao J}, journal={Urology}}"}}, {"_id": "37805050", "pmid": 37805050, "title": "The use of Metformin in overactive bladder - a retrospective nested case-control, population-based analysis.", "journal": "Urology", "authors": ["Neu S", "Matta R", "Locke JA", "Troke N", "Tadrous M", "Saskin R", "Rebullar K", "Nam R", "Herschorn S"], "date": "2023-10-05T00:00:00Z", "doi": "10.1016/j.urology.2023.09.033", "meta_date_publication": "2023 Oct 5", "meta_volume": "", "meta_issue": "", "meta_pages": "", "score": 50269.25, "text_hl": "The use of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ in @<m>DISEASE_Urinary_Bladder_Overactive</m> @DISEASE_MESH:D053201 @@@overactive bladder@@@ - a retrospective nested case-control, population-based analysis.", "citations": {"NLM": "Neu S, Matta R, Locke JA, Troke N, Tadrous M, Saskin R, Rebullar K, Nam R, Herschorn S. The use of Metformin in overactive bladder - a retrospective nested case-control, population-based analysis. Urology. 2023 Oct 5;():. PMID: 37805050", "BibTeX": "@article{37805050, title={The use of Metformin in overactive bladder - a retrospective nested case-control, population-based analysis.}, author={Neu S and Matta R and Locke JA and Troke N and Tadrous M and Saskin R and Rebullar K and Nam R and Herschorn S}, journal={Urology}}"}}, {"_id": "34076286", "pmid": 34076286, "title": "Vitamin D status determines the impact of metformin on circulating prolactin levels in premenopausal women.", "journal": "J Clin Pharm Ther", "authors": ["Krysiak R", "Kowalcze K", "Okopień B"], "date": "2021-10-01T00:00:00Z", "doi": "10.1111/jcpt.13447", "meta_date_publication": "2021 Oct", "meta_volume": "46", "meta_issue": "5", "meta_pages": "1349-1356", "score": 50245.383, "text_hl": "The drug produced a neutral effect on circulating levels of thyrotropin, free thyroid hormones, gonadotropins, @CHEMICAL_Estradiol @CHEMICAL_MESH:D004958 @@@estradiol@@@, @CHEMICAL_Calcium @CHEMICAL_MESH:D002118 @@@calcium@@@ and @CHEMICAL_25_hydroxyvitamin_D @CHEMICAL_MESH:C104450 @@@25-hydroxyvitamin D.@@@ WHAT IS NEW AND THE CONCLUSION: The results of the current study suggest that the impact of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ on secretory function of @<m>DISEASE_Urinary_Bladder_Overactive</m> @DISEASE_MESH:D053201 @@@overactive lactotropes@@@ depends on the @CHEMICAL_Vitamin_D @CHEMICAL_MESH:D014807 @@@vitamin D@@@ status of @SPECIES_9606 @@@patients@@@.", "citations": {"NLM": "Krysiak R, Kowalcze K, Okopień B. Vitamin D status determines the impact of metformin on circulating prolactin levels in premenopausal women. J Clin Pharm Ther. 2021 Oct;46(5):1349-1356. PMID: 34076286", "BibTeX": "@article{34076286, title={Vitamin D status determines the impact of metformin on circulating prolactin levels in premenopausal women.}, author={Krysiak R and Kowalcze K and Okopień B}, journal={J Clin Pharm Ther}, volume={46}, number={5}, pages={1349-1356}}"}}, {"_id": "31234219", "pmid": 31234219, "title": "The Impact of Ethinyl Estradiol on Metformin Action on Prolactin Levels in Women with Hyperprolactinemia.", "journal": "Exp Clin Endocrinol Diabetes", "authors": ["Krysiak R", "Szkróbka W", "Okopień B"], "date": "2021-01-01T00:00:00Z", "doi": "10.1055/a-0921-6420", "meta_date_publication": "2021 Jan", "meta_volume": "129", "meta_issue": "1", "meta_pages": "22-28", "score": 50245.31, "text_hl": "CONCLUSIONS: The obtained results suggest that the effect of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ on @<m>DISEASE_Urinary_Bladder_Overactive</m> @DISEASE_MESH:D053201 @@@overactive lactotropes@@@ depends on estrogen levels.", "citations": {"NLM": "Krysiak R, Szkróbka W, Okopień B. The Impact of Ethinyl Estradiol on Metformin Action on Prolactin Levels in Women with Hyperprolactinemia. Exp Clin Endocrinol Diabetes. 2021 Jan;129(1):22-28. PMID: 31234219", "BibTeX": "@article{31234219, title={The Impact of Ethinyl Estradiol on Metformin Action on Prolactin Levels in Women with Hyperprolactinemia.}, author={Krysiak R and Szkróbka W and Okopień B}, journal={Exp Clin Endocrinol Diabetes}, volume={129}, number={1}, pages={22-28}}"}}, {"_id": "38369198", "pmid": 38369198, "title": "Reply to Shuying Jang, Ruiquin Wang, and Jian Liao's Letter to the Editor re: Neu S, Matta R, Locke JA, et al. The use of metformin in overactive bladder: a retrospective nested case-control, population-based analysis. Urology. 2023 Oct 5:S0090-4295(23)00871-3.", "journal": "Urology", "authors": ["Neu S", "Matta R", "Locke JA", "Troke N", "Tadrous M", "Saskin R", "Rebullar K", "Nam R", "Herschorn S"], "date": "2024-02-16T00:00:00Z", "doi": "10.1016/j.urology.2023.12.030", "meta_date_publication": "2024 Feb 16", "meta_volume": "", "meta_issue": "", "meta_pages": "", "score": 50240.25, "text_hl": "Reply to Shuying Jang, Ruiquin Wang, and Jian Liao's Letter to the Editor re: Neu S, Matta R, Locke JA, et al. The use of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ in @<m>DISEASE_Urinary_Bladder_Overactive</m> @DISEASE_MESH:D053201 @@@overactive bladder@@@: a retrospective nested case-control, population-based analysis. ", "citations": {"NLM": "Neu S, Matta R, Locke JA, Troke N, Tadrous M, Saskin R, Rebullar K, Nam R, Herschorn S. Reply to Shuying Jang, Ruiquin Wang, and Jian Liao's Letter to the Editor re: Neu S, Matta R, Locke JA, et al. The use of metformin in overactive bladder: a retrospective nested case-control, population-based analysis. Urology. 2023 Oct 5:S0090-4295(23)00871-3. Urology. 2024 Feb 16;():. PMID: 38369198", "BibTeX": "@article{38369198, title={Reply to Shuying Jang, Ruiquin Wang, and Jian Liao's Letter to the Editor re: Neu S, Matta R, Locke JA, et al. The use of metformin in overactive bladder: a retrospective nested case-control, population-based analysis. Urology. 2023 Oct 5:S0090-4295(23)00871-3.}, author={Neu S and Matta R and Locke JA and Troke N and Tadrous M and Saskin R and Rebullar K and Nam R and Herschorn S}, journal={Urology}}"}}, {"_id": "16331111", "pmid": 16331111, "title": "Insulin resistance and sympathetic overactivity in women.", "journal": "J Hypertens", "authors": ["Kaaja RJ", "Pöyhönen-Alho MK"], "date": "2006-01-01T00:00:00Z", "doi": "10.1097/01.hjh.0000194121.19851.e5", "meta_date_publication": "2006 Jan", "meta_volume": "24", "meta_issue": "1", "meta_pages": "131-41", "score": 50058.92, "text_hl": "@DISEASE_Insulin_Resistance @DISEASE_MESH:D007333 @@@Insulin resistance@@@ and @<m>DISEASE_Urinary_Bladder_Overactive</m> @DISEASE_MESH:D053201 @@@sympathetic overactivity@@@ in @SPECIES_9606 @@@women@@@.", "citations": {"NLM": "Kaaja RJ, Pöyhönen-Alho MK. Insulin resistance and sympathetic overactivity in women. J Hypertens. 2006 Jan;24(1):131-41. PMID: 16331111", "BibTeX": "@article{16331111, title={Insulin resistance and sympathetic overactivity in women.}, author={Kaaja RJ and Pöyhönen-Alho MK}, journal={J Hypertens}, volume={24}, number={1}, pages={131-41}}"}}]}